Jain Global’s AbbVie ABBV Stock Holding History

Jain Global’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.03M	Buy	+20,000	New	+$4.3M	0.02%	571

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jain Global's ABBV Position: Q2 2026 in Review

Jain Global increased its AbbVie (ABBV) stake by 43% in Q2 2026, buying an estimated $12.7M and bringing the position to 197,926 shares worth $49.8M. The position accounts for 0.2% of the portfolio, ranked #95.

Jain Global first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jain Global held 197,926 shares of AbbVie worth $49.8M as of Q2 2026.
Jain Global bought 59,239 AbbVie shares in Q2 2026, an estimated $12.7M.
AbbVie made up 0.2% of Jain Global's portfolio in Q2 2026, its #95 holding.
Jain Global first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.